Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Prevention of Central Pain in SCI
NCT03748290Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Aug 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in Central pain syndrome (CPS), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
pregabalin
03
Conditions
Central pain syndrome (CPS)
Beyond the preview
Go deeper on NCT03748290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748290.